GLP1R and cocaine abuse: Both GLP1 and hBChE have very short half-lives in vivo [24, 25], however, and the use of GLP1 receptor agonists requires long-term and parenteral administration which may be inconvenient and costly for patients, limiting their potential in treating alcohol and/or cocaine abuse.